Understanding Your Child's Diagnosis of Autosomal Recessive Sideroblastic Anemia
At a Glance
Autosomal recessive congenital sideroblastic anemia (AR-CSA) is a rare inherited condition present from birth in which gene changes prevent cells from using iron normally to make hemoglobin. It is not caused by anything parents did during pregnancy.
Hearing that your child has a rare genetic condition like Autosomal Recessive Congenital Sideroblastic Anemia (AR-CSA) is often an overwhelming experience. It is natural to feel a wave of emotions—fear, confusion, and even a heavy sense of guilt [1][2]. Please know that you did nothing to cause this. This condition is congenital, meaning it is present from birth because of the way a child’s DNA is structured [3]. It is not the result of anything you did, ate, or experienced during pregnancy.
What is AR-CSA?
Autosomal Recessive Congenital Sideroblastic Anemia is not just one disease. It is a group of rare, inherited disorders where the body cannot properly use iron to make hemoglobin (the protein in red blood cells that carries oxygen) [4][3].
In a healthy body, iron moves into the mitochondria—the “power plants” of the cell—and is incorporated into protoporphyrin IX during heme synthesis [4]. In children with AR-CSA, a genetic “glitch” prevents the mitochondria from using that iron correctly [5]. Because the iron can’t be used, it piles up inside the mitochondria, forming a circle around the center of the cell. When doctors look at these cells under a microscope using a special blue stain, they see these circles and call them ring sideroblasts [4][5].
Understanding “Autosomal Recessive”
The term autosomal recessive describes how the condition is passed down through families. We all have two copies of most genes—one from each parent.
- Carriers: Most parents of a child with AR-CSA are “carriers.” This means they have one healthy copy of the gene and one altered copy (pathogenic variant). Carriers usually have no symptoms and no idea they carry the gene [6].
- Recessive Inheritance: For a child to have AR-CSA, they typically must inherit an altered copy of the gene from both parents [7].
Because these pathogenic variants are hidden in carriers, there is often no family history of the disease. It can feel like the diagnosis came out of nowhere, but it is simply a matter of genetic chance [7][8]. Note that if your test identifies a “Variant of Uncertain Significance” (VUS), it means a change was found but there isn’t enough medical evidence to know if it causes the disease; a genetic counselor can help clarify what this means.
Family Planning and Testing: Sibling testing, carrier testing for family members, and reproductive counseling are complex. Carrier status does not predict how severely an affected child will be ill. Consult a genetic counselor for personalized guidance.
A Group of Different Genetic “Glitches”
Because AR-CSA is a group of disorders, your child’s experience will depend on which specific gene is affected. Some of the most common genes involved include:
- SLC25A38: This is the most common cause of the recessive form [9]. It affects a “transporter” that brings a vital ingredient (glycine) into the mitochondria to start making heme [10].
- GLRX5 and HSPA9: These genes help build “clusters” of iron and sulfur that the mitochondria need to function [11][12]. When these are missing, the cell’s iron handling breaks down.
Each gene mutation can lead to different levels of anemia. Some children may need frequent blood transfusions, while others may have milder symptoms [13][9].
Congenital vs. Acquired: Why the Distinction Matters
You may see information online about “Sideroblastic Anemia” being linked to Myelodysplastic Syndrome (MDS), a type of blood disorder. It is important to know that AR-CSA is very different:
- Congenital (Your child’s type): This is something a child is born with. It is caused by an inherited genetic instruction and is not a form of cancer [3][7].
- Acquired: This version develops later in life, often due to toxins, medications, nutritional deficiencies, or clonal myeloid neoplasms like MDS [14][4].
While both types show “ring sideroblasts” under a microscope, they have different causes and require different care [14].
The Challenge of Rarity
AR-CSA is exceptionally rare. For example, early studies on the SLC25A38 type found fewer than 70 affected families in the entire world, though reported numbers grow as genetic testing expands [9]. Because it is so rare:
- Local Knowledge May Be Limited: Your local pediatrician or general hematologist may have never treated a child with this specific condition before [15].
- You May Become the Expert: Parents of children with rare diseases often find themselves “educating the doctor” or coordinating care between many different specialists [16][17].
- Diagnosis Can Take Time: It is common for families to go through years of testing or be misdiagnosed with more common problems like iron deficiency before finding the right answer through genetic testing [18][15].
Validating Your Feelings
It is okay to feel a sense of “culture shock” or grief for the future you imagined for your child [19][20]. You may feel isolated, especially if you don’t know anyone else with the same diagnosis. Seeking out a genetic counselor can be very helpful—not just to understand the science, but to help process the impact this has on your family [21][22]. Connecting with rare-disease advocacy groups can also provide a community of people who understand the unique challenges of raising a child with a rare condition [23].
Common questions in this guide
What is autosomal recessive congenital sideroblastic anemia?
How did my child inherit AR-CSA if no one in our family is sick?
Did something I did during pregnancy cause my child's AR-CSA?
Is congenital sideroblastic anemia the same as sideroblastic anemia from MDS?
What genes can cause AR-CSA?
What does a variant of uncertain significance mean?
What kind of specialist can help our family?
Get notified when new evidence is published on Autosomal recessive sideroblastic anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
The supportive care needs of parents with a child with a rare disease: results of an online survey.
Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ
BMC family practice 2016; (17()):88 doi:10.1186/s12875-016-0488-x.
PMID: 27439905 - 2
The supportive care needs of parents caring for a child with a rare disease: A scoping review.
Pelentsov LJ, Laws TA, Esterman AJ
Disability and health journal 2015; (8(4)):475-91.
PMID: 25959710 - 3
Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology.
Long Z, Li H, Du Y, Han B
Gene 2018; (668()):182-189 doi:10.1016/j.gene.2018.05.074.
PMID: 29787825 - 4
Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ, Calvo X, Arenillas L
Genes 2022; (13(9)) doi:10.3390/genes13091562.
PMID: 36140729 - 5
Iron Metabolism in the Disorders of Heme Biosynthesis.
Ricci A, Di Betto G, Bergamini E, et al.
Metabolites 2022; (12(9)) doi:10.3390/metabo12090819.
PMID: 36144223 - 6
Novel mutations in mitochondrial carrier family gene SLC25A38, causing congenital sideroblastic anemia in Iranian families, identified by whole exome sequencing.
Mehri M, Zarin M, Ardalani F, et al.
Blood cells, molecules & diseases 2018; (71()):39-44 doi:10.1016/j.bcmd.2018.02.002.
PMID: 29499877 - 7
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Abu-Zeinah G, DeSancho MT
Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.
PMID: 33061728 - 8
A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.
Cai J, Liu T, Huang Y, et al.
Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.
PMID: 39281190 - 9
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.
Heeney MM, Berhe S, Campagna DR, et al.
Human mutation 2021; (42(11)):1367-1383 doi:10.1002/humu.24267.
PMID: 34298585 - 10
Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.
Lunetti P, Damiano F, De Benedetto G, et al.
The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.
PMID: 27476175 - 11
GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R, Mansouri A, Martelli A, et al.
Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.
PMID: 30660387 - 12
Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, et al.
Blood 2015; (126(25)):2734-8 doi:10.1182/blood-2015-09-659854.
PMID: 26491070 - 13
Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients.
Dongerdiye R, Kedar PS, Saptarshi A, et al.
Annals of hematology 2024; (103(10)):3987-3998 doi:10.1007/s00277-024-05969-5.
PMID: 39196378 - 14
When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.
Girard S, Genevieve F, Rault E, et al.
Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.
PMID: 35885655 - 15
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
Zurynski Y, Deverell M, Dalkeith T, et al.
Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.
PMID: 28399928 - 16
The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.
Bauskis A, Strange C, Molster C, Fisher C
Orphanet journal of rare diseases 2022; (17(1)):233 doi:10.1186/s13023-022-02358-x.
PMID: 35717227 - 17
Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.
Baumbusch J, Mayer S, Sloan-Yip I
Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.
PMID: 30128673 - 18
Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias.
Shefer Averbuch N, Steinberg-Shemer O, Dgany O, et al.
European journal of haematology 2018; (101(3)):297-304 doi:10.1111/ejh.13097.
PMID: 29786897 - 19
Rare and resilient: Longer-term experiences of families after genetic evaluation in the neonatal intensive care unit.
Abouhala S, Del Rosario MC, Holm IA, Wojcik MH
Genetics in medicine open 2026; (4()):103490 doi:10.1016/j.gimo.2025.103490.
PMID: 41657716 - 20
"I don't grieve as much as I used to": A qualitative study on parents of children with rare and undiagnosed conditions navigating grief in the context of uncertainty.
Hoffmann TM, Friedrich B, Lewis C
Journal of genetic counseling 2025; (34(6)):e70149 doi:10.1002/jgc4.70149.
PMID: 41317142 - 21
Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.
Smits RM, Vissers E, Te Pas R, et al.
Orphanet journal of rare diseases 2022; (17(1)):153 doi:10.1186/s13023-022-02305-w.
PMID: 35379257 - 22
How parents of children with ataxia-telangiectasia use dynamic coping to navigate cyclical uncertainty.
Schiller J, Towne MC, Epstein R, et al.
Journal of genetic counseling 2024; (33(2)):301-313 doi:10.1002/jgc4.1727.
PMID: 37183503 - 23
Improving Social Media-Based Support Groups for the Rare Disease Community: Interview Study With Patients and Parents of Children with Rare and Undiagnosed Diseases.
Doyle TA, Vershaw SL, Conboy E, Halverson CME
JMIR human factors 2024; (11()):e57833 doi:10.2196/57833.
PMID: 39752188
This page is for informational purposes only and does not constitute medical advice. Your child's pediatric hematologist and genetic counselor can interpret genetic findings and recommend care for your family.